Mid-term efficacy of castor stent and in situ fenestration stent in the treatment of type B aortic dissection involving the left subclavian artery: A retrospective single-center study,Journal of Clinical Hypertension

当前位置： X-MOL 学术 › J. Clin. Hypertens. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Mid-term efficacy of castor stent and in situ fenestration stent in the treatment of type B aortic dissection involving the left subclavian artery: A retrospective single-center study
Journal of Clinical Hypertension ( IF 2.8 ) Pub Date : 2023-12-28 , DOI: 10.1111/jch.14752
Qingsong Wu _{1,

2,

3} , Lin‐feng Xie ₂ , Huangwei Li ₂ , Yue Shen _{1,

2,

3} , Zhihuang Qiu _{1,

3,

4} , Liangwan Chen _{1,

3,

4}

Affiliation

To evaluate the midterm efficacy of the Castor stent (CS) versus in situ fenestration (ISF) for reconstructing the left subclavian artery (LSA) in patients with type B aortic dissection (TBAD).

中文翻译：